Company page

Neogenomics, Inc.

Neogenomics, Inc. is a public company traded under the ticker NEO in the American market. The company has a market capitalization of approximately $1.9 billion. Neogenomics specializes in cancer genetics testing and provides comprehensive diagnostic services to healthcare providers.